Adults Receiving Renal Replacement Therapy
Conditions
Keywords
Renal replacement therapy, Hemofilter clotting, Clotting risk factor, Hemofilter clotting prevention
Brief summary
This is a prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.
Detailed description
Prospective before / after observational clinical multicentric study on ICU acute kidney injury during renal replacement therapy. Evaluation of incidence and exposure to hemofilter clotting. The after phase will consist in medical measures (help for prescription) and paramedical measures (stop the filtration flow during the patient's mobilization).
Interventions
OTHERrenal replacement therapy
Prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.
Sponsors
University Hospital, Clermont-Ferrand
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult (age \> 18 years) * Renal replacement therapy (continuous veino-veinous hemofiltration or continuous veino-veinous hemodiafiltration) * Consent of patients
Exclusion criteria
* Use citrate anticoagulation * Age below 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemofilter lifetime | at day 1 |
Secondary
| Measure | Time frame |
|---|---|
| hemofiltration duration | at day 1 |
| Hemofilter clotting risk factors | at day 1 |
| down time value | at day 1 |
Countries
France
Outcome results
None listed